European Perspectives on Pain And Palliative Care

REFERENCES

• Council of Health and Consumer Affairs. Program for pain evaluation and treatment in Extremadura. Government of the Autonomous Community of Extremadura, Spain 2004
   Google Scholar
• Sandler R S, Stewart W F, Liberman J N, et al. Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci 2000; 45: 1166–1171
   PubMed Web of Science ®Google Scholar
• Arendt-Nielsen L, Schipper K P, Dimcevski G, et al. Viscero-somatic reflexes in referred pain areas evoked by capsaicin stimulation of the human gut. Eur J Pain 2008; 12: 544–551
   PubMed Web of Science ®Google Scholar
• Cervero F. Mechanisms of visceral pain: past and present. Visceral Pain. Progress in Pain Research and Management, G F Gebhart. IASP Press, Seattle 1995; 25–40
   Google Scholar
• Bueno L, Fioramonti J, Garcia-Villar R. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain. Am J Physiol Gastrointest Liver Physiol 2000; 278: G670–G676
   Web of Science ®Google Scholar
• Arendt-Nielsen L, Laursen R J, Drewes A M. Referred pain as an indicator for neural plasticity. Prog Brain Res 2000; 129: 343–356
   PubMedGoogle Scholar
• Sengupta J N, Snider A, Su X, et al. Effects of kappa opioids in the inflamed rat colon. Pain 1999; 79: 175–185
   PubMed Web of Science ®Google Scholar
• Staahl C, Christrup L L, Andersen S D, et al. A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model. Pain 2006; 123: 28–36
   PubMed Web of Science ®Google Scholar
• Staahl C, Dimcevski G, Andersen S D, et al. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study. Scand J Gastroenterol 2007; 42: 383–390
   PubMed Web of Science ®Google Scholar
• Suzuki R, Rahman W, Rygh L J, et al. Spinal-supraspinal serotonergic circuits regulating neuropathic pain and its treatment with gabapentin. Pain 2005; 117: 292–303
   PubMed Web of Science ®Google Scholar
• Hanna M, O'Brien C, Wilson M C. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 2008; 12: 804–813
   PubMed Web of Science ®Google Scholar
• Reimer K, Hopp M, Zenz M, et al. Meeting the challenges of opioid induced constipation in chronic pain management: a novel approach. Pharmacology 2009; 83: 10–17
   PubMed Web of Science ®Google Scholar
• Bell T J, Panchal S J, Miaskowski C, et al. The prevalence, severity, and impact of opioid induced bowel dysfunction: results of a US and European patient survey (PROBE 1). Pain Med, Epub 2008 August 20
   Web of Science ®Google Scholar
• Cook S F, Lanza L, Zhou X, et al. Gastrointestinal side effects in chronic opioid users: results from a population-based survey. Aliment Pharmacol Ther 2008; 27: 1224–1232
   PubMed Web of Science ®Google Scholar
• Brennan F, Carr D B, Cousins M. Pain management: a fundamental human right. Anesth Analg 2007; 105: 205–221
   PubMed Web of Science ®Google Scholar
• Bell T J, Panchal S J, Miaskowski C, et al. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European patient survey (PROBE 1). Pain Med, Epub 2008 August 20
   Web of Science ®Google Scholar
• Sykes N. Constipation and diarrhoea. Oxford Textbook of Palliative Medicine, D Doyle, G Hanks, N Cherny, et al. Oxford University Press, Oxford 2004
   Google Scholar
• Meissner W, Leyendecker P, Mueller-Lissner S, et al. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain 2009; 13: 56–64
   PubMed Web of Science ®Google Scholar
• Thomas J. Opioid-induced bowel dysfunction. J Pain Symptom Manage 2008; 35: 103–13
   PubMed Web of Science ®Google Scholar
• Miles C L, Fellowes D, Goodman M L, et al. Laxatives for the management of constipation in palliative care patients. Cochrane Database Syst Rev 2006; 4
   Google Scholar
• Holzer P. Treatment of opioid-induced gut dysfunction. Expert Opin Investig Drugs 2007; 16: 181–94
   PubMed Web of Science ®Google Scholar
• McNicol E D, Boyce D, Schumann R, et al. Mu-opioid antagonists for opioid-induced bowel dysfunction. Cochrane Database Syst Rev 2008; 2
   Google Scholar
• Thomas J, Karver S, Cooney G A, et al. Methylnaltrexone for opioid induced constipation in advanced illness. N Engl J Med 2008; 358: 2332–2343
   PubMed Web of Science ®Google Scholar
• Büchler M W, Seiler C M, Monson J R, et al. Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo controlled clinical study. Aliment Pharmacol Ther 2008; 28: 312–325
   PubMed Web of Science ®Google Scholar
• Webster L, Jansen J P, Peppin J, et al. Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain. Pain 2008; 137: 428–440
   PubMed Web of Science ®Google Scholar
• Traut U, Brügger L, Kunz R, et al. Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal surgery in adults. Cochrane Database Syst Rev 2008; 1
   Google Scholar
• Nadstawek J, Leyendecker P, Hopp M, et al. Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain. Int J Clin Pract 2008; 62: 1159–1167
   PubMed Web of Science ®Google Scholar
• Vondrackova D, Leyendecker P, Meissner W, et al. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain. J Pain 2008; 9: 1144–1154
   PubMed Web of Science ®Google Scholar
• Simpson K, Leyendecker P, Hopp M, et al. Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe non-cancer pain. Curr Med Res Opin 2008; 24: 3503–3512
   PubMed Web of Science ®Google Scholar
• Panchal S J, Müller-Schwefe P, Wurzelmann J I. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract 2007; 61: 1181–1187
   PubMed Web of Science ®Google Scholar
• Thomas J. Opioid-induced bowel dysfunction. J Pain Symptom Manage 2008; 35: 103–113
   PubMed Web of Science ®Google Scholar
• Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 2001; 182(5 Suppl 1)S11–S18
   Google Scholar
• Choi Y S, Billings J A. Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation. J Pain Symptom Manage 2002; 24: 71–90
   PubMed Web of Science ®Google Scholar
• Boneschi F M, Colombo B, Annovazzi P, et al. Lifetime and actual prevalence of pain and headache in multiple sclerosis. Mult Scler 2008; 14: 514–521
   PubMed Web of Science ®Google Scholar
• Piwko C, Desjardins O B, Bereza B G, et al. Pain due to multiple sclerosis: analysis of the prevalence and economic burden in Canada. Pain Res Manag 2007; 12: 259–265
   PubMed Web of Science ®Google Scholar
• Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalagia 2004; 24(Suppl 1)9–160
   PubMed Web of Science ®Google Scholar
• Pringsheim T, Davenport W J, Dodick D. Acute treatment and prevention of menstrually related migraine headache: evidence-based review. Neurology 2008; 70: 1555–1563
   PubMed Web of Science ®Google Scholar
• Ben-Ari A, Lewis M C, Davidson E. Chronic administration of ketamine for analgesia. J Pain Palliat Care Pharmacother 2007; 21: 7–14
   PubMedGoogle Scholar
• Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006; 10: 287–333
   PubMed Web of Science ®Google Scholar
• Tunks E R, Crook J, Weir R. Epidemiology of chronic pain with psychological comorbidity: prevalence, risk, course, and prognosis. Can J Psychiatry 2008; 53: 224–234
   PubMed Web of Science ®Google Scholar
• Fishbain D A, Detke M J, Wernicke J, et al. The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder. Curr Med Res Opin 2008; 24: 3105–3115
   PubMed Web of Science ®Google Scholar